BioLife Solutions Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,084.20
3,134.70
4,995.40
8,041.40
2,515.10
3,266
Depreciation, Depletion & Amortization
247.10
258.10
343.20
368.10
338.70
338
Other Funds
357.00
342.50
474.60
3,879.00
2,478.60
2,064
Funds from Operations
480.10
2,534.10
4,177.60
3,794.20
302.20
5,668
Changes in Working Capital
626.10
628.20
796.30
532.80
302.90
3,320
Net Operating Cash Flow
146.00
3,162.30
4,973.90
4,327.00
605.10
2,348
Capital Expenditures
236.70
589.70
1,417.70
1,257.20
143.80
Sale of Fixed Assets & Businesses
-
4.40
-
-
-
Purchase/Sale of Investments
-
7,549.70
5,657.30
1,650.00
-
Net Investing Cash Flow
236.70
8,135.00
4,239.60
392.80
143.80
Cash Dividends Paid - Total
-
-
-
-
106.30
Issuance/Reduction of Debt, Net
50.50
-
-
3,000.00
976.00
Net Financing Cash Flow
50.50
13,679.80
368.80
3,166.80
4,796.10
Net Change in Cash
40.20
2,382.50
365.50
767.40
5,257.50
Free Cash Flow
90.70
3,752.00
5,107.90
4,470.50
461.40
Change in Capital Stock
-
13,679.80
368.80
166.80
3,926.40

About BioLife Solutions

View Profile
Address
3303 Monte Villa Parkway
Bothell Washington 98021
United States
Employees -
Website http://www.biolifesolutions.com
Updated 07/08/2019
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of portfolio of biopreservation tools for cells, tissues, and organs including proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media. Its products include CryoStor, BloodStor, HypoThermosol FRS, and Cell Thawing Media. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.